Delivery of nucleic acid therapeutics for cancer immunotherapy
Cancer immunotherapy has shown great potential as witnessed by an increasing number of immuno-oncology drug approvals in the past few years. Meanwhile, the field of nucleic acid therapeutics has made significant advancement. Nucleic acid therapeutics, such as plasmids, antisense oligonucleotides (AS...
Main Authors: | Shurong Zhou, Wenjie Chen, Janet Cole, Guizhi Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Medicine in Drug Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590098620300105 |
Similar Items
-
Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications
by: Wenzhang Cha, et al.
Published: (2017-05-01) -
Development of Spherical Nucleic Acids for Prostate Cancer Immunotherapy
by: Lei Qin, et al.
Published: (2020-07-01) -
Elucidation and optimization of the interaction of nanostructured DNA and immune cells.
by: Ohtsuki, Shozo
Published: (2018) -
Recent Developments in Peptide-Based Nucleic Acid Delivery
by: Tobias Restle, et al.
Published: (2008-07-01) -
At the Intersection of Biomaterials and Gene Therapy: Progress in Non-viral Delivery of Nucleic Acids
by: Hasan Uludag, et al.
Published: (2019-06-01)